These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 35925472)

  • 1. CRISPR-Cas12a-Empowered Electrochemical Biosensor for Rapid and Ultrasensitive Detection of SARS-CoV-2 Delta Variant.
    Wu C; Chen Z; Li C; Hao Y; Tang Y; Yuan Y; Chai L; Fan T; Yu J; Ma X; Al-Hartomy OA; Wageh S; Al-Sehemi AG; Luo Z; He Y; Li J; Xie Z; Zhang H
    Nanomicro Lett; 2022 Aug; 14(1):159. PubMed ID: 35925472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR-Cas13a-powered electrochemical biosensor for the detection of the L452R mutation in clinical samples of SARS-CoV-2 variants.
    Chen Z; Wu C; Yuan Y; Xie Z; Li T; Huang H; Li S; Deng J; Lin H; Shi Z; Li C; Hao Y; Tang Y; You Y; Al-Hartomy OA; Wageh S; Al-Sehemi AG; Lu R; Zhang L; Lin X; He Y; Zhao G; Li D; Zhang H
    J Nanobiotechnology; 2023 Apr; 21(1):141. PubMed ID: 37120637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reverse Transcription Recombinase Polymerase Amplification Coupled with CRISPR-Cas12a for Facile and Highly Sensitive Colorimetric SARS-CoV-2 Detection.
    Zhang WS; Pan J; Li F; Zhu M; Xu M; Zhu H; Yu Y; Su G
    Anal Chem; 2021 Mar; 93(8):4126-4133. PubMed ID: 33570401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR-Cas12a-Based Detection for the Major SARS-CoV-2 Variants of Concern.
    Liang Y; Lin H; Zou L; Zhao J; Li B; Wang H; Lu J; Sun J; Yang X; Deng X; Tang S
    Microbiol Spectr; 2021 Dec; 9(3):e0101721. PubMed ID: 34787487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A smartphone-based visual biosensor for CRISPR-Cas powered SARS-CoV-2 diagnostics.
    Ma L; Yin L; Li X; Chen S; Peng L; Liu G; Ye S; Zhang W; Man S
    Biosens Bioelectron; 2022 Jan; 195():113646. PubMed ID: 34624801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current state of diagnostic, screening and surveillance testing methods for COVID-19 from an analytical chemistry point of view.
    Martín J; Tena N; Asuero AG
    Microchem J; 2021 Aug; 167():106305. PubMed ID: 33897053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Customization of aptamer to develop CRISPR/Cas12a-derived ultrasensitive biosensor.
    Xing W; Li Q; Han C; Sun D; Zhang Z; Fang X; Guo Y; Ge F; Ding W; Luo Z; Zhang L
    Talanta; 2023 May; 256():124312. PubMed ID: 36738621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR-Cas12a-mediated label-free electrochemical aptamer-based sensor for SARS-CoV-2 antigen detection.
    Liu N; Liu R; Zhang J
    Bioelectrochemistry; 2022 Aug; 146():108105. PubMed ID: 35367933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitive and rapid on-site detection of SARS-CoV-2 using a gold nanoparticle-based high-throughput platform coupled with CRISPR/Cas12-assisted RT-LAMP.
    Zhang Y; Chen M; Liu C; Chen J; Luo X; Xue Y; Liang Q; Zhou L; Tao Y; Li M; Wang D; Zhou J; Wang J
    Sens Actuators B Chem; 2021 Oct; 345():130411. PubMed ID: 34248284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrochemical biosensor for nucleic acid amplification-free and sensitive detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA via CRISPR/Cas13a trans-cleavage reaction.
    Heo W; Lee K; Park S; Hyun KA; Jung HI
    Biosens Bioelectron; 2022 Apr; 201():113960. PubMed ID: 35016109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid, Ultrasensitive, and Highly Specific Diagnosis of COVID-19 by CRISPR-Based Detection.
    Zhu X; Wang X; Li S; Luo W; Zhang X; Wang C; Chen Q; Yu S; Tai J; Wang Y
    ACS Sens; 2021 Mar; 6(3):881-888. PubMed ID: 33645226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A strategy combining 3D-DNA Walker and CRISPR-Cas12a trans-cleavage activity applied to MXene based electrochemiluminescent sensor for SARS-CoV-2 RdRp gene detection.
    Zhang K; Fan Z; Huang Y; Ding Y; Xie M
    Talanta; 2022 Jan; 236():122868. PubMed ID: 34635250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PAM-free cascaded strand displacement coupled with CRISPR-Cas12a for amplified electrochemical detection of SARS-CoV-2 RNA.
    Shi K; Yi Z; Han Y; Chen J; Hu Y; Cheng Y; Liu S; Wang W; Song J
    Anal Biochem; 2023 Mar; 664():115046. PubMed ID: 36641031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrasensitive electrochemical biosensors based on zinc sulfide/graphene hybrid for rapid detection of SARS-CoV-2.
    Sarwar S; Lin MC; Amezaga C; Wei Z; Iyayi E; Polk H; Wang R; Wang H; Zhang X
    Adv Compos Hybrid Mater; 2023; 6(1):49. PubMed ID: 36718472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A CRISPR-Cas12a-derived biosensor enabling portable personal glucose meter readout for quantitative detection of SARS-CoV-2.
    Huang D; Shi Z; Qian J; Bi K; Fang M; Xu Z
    Biotechnol Bioeng; 2021 Apr; 118(4):1587-1596. PubMed ID: 33410130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid, Ultrasensitive, and Quantitative Detection of SARS-CoV-2 Using Antisense Oligonucleotides Directed Electrochemical Biosensor Chip.
    Alafeef M; Dighe K; Moitra P; Pan D
    ACS Nano; 2020 Dec; 14(12):17028-17045. PubMed ID: 33079516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of Isothermal Recombinase-Aided Amplification and CRISPR-Cas12a-Mediated Assay for Rapid Detection of Major Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern.
    Lin H; Liang Y; Zou L; Li B; Zhao J; Wang H; Sun J; Deng X; Tang S
    Front Microbiol; 2022; 13():945133. PubMed ID: 35836420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid electrochemical detection of coronavirus SARS-CoV-2.
    Chaibun T; Puenpa J; Ngamdee T; Boonapatcharoen N; Athamanolap P; O'Mullane AP; Vongpunsawad S; Poovorawan Y; Lee SY; Lertanantawong B
    Nat Commun; 2021 Feb; 12(1):802. PubMed ID: 33547323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contamination-free visual detection of SARS-CoV-2 with CRISPR/Cas12a: A promising method in the point-of-care detection.
    Chen Y; Shi Y; Chen Y; Yang Z; Wu H; Zhou Z; Li J; Ping J; He L; Shen H; Chen Z; Wu J; Yu Y; Zhang Y; Chen H
    Biosens Bioelectron; 2020 Dec; 169():112642. PubMed ID: 32979593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of the amplification-free SERS-based CRISPR/Cas12a platform in the identification of SARS-CoV-2 from clinical samples.
    Liang J; Teng P; Xiao W; He G; Song Q; Zhang Y; Peng B; Li G; Hu L; Cao D; Tang Y
    J Nanobiotechnology; 2021 Sep; 19(1):273. PubMed ID: 34496881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.